Effect of EGFR-inhibition on the radiation response of oral mucosa: experimental studies in mouse tongue epithelium.
The aim was to quantify the effect of selective inhibition of the epidermal growth factor receptor (EGFR) on the radiation response of mouse oral mucosa to daily fractionated irradiation. Irradiation comprised graded single doses of 25 kV X-rays to the lower tongue surface or fractionated doses of 5 x 3 Gy week(-1) (200 kV X-rays) over 1 or 2 weeks, followed by graded local doses, to generate full dose-effect curves. For selective inhibition of EGFR, BIBX1382BS, a tyrosine kinase inhibitor, was administered orally at a dose of 50 mg kg(-1), for the entire overall treatment time. The ED50 (the dose expected to induce ulcer in 50% of the mice) for untreated mucosa was 11.9 +/- 1.2 Gy. Fractionated irradiation administered over 1 or 2 weeks yielded ED50 values for the concluding test irradiation of 6.7 +/- 2.1 and 6.5 +/- 1.9 Gy, respectively. Administration of BIBX1382BS resulted in a non-significant increase of the top-up ED50 to 8.3 +/- 1.6 Gy (p = 0.1197) after 1 week and to 7.6 +/- 1.6 Gy (p = 0.2263) after 2 weeks. EGFR inhibition does not alter the radiation response of oral mucosa to fractionated irradiation or interfere with mucosal repopulation processes. This indicates that the regulation of mucosal repopulation is largely independent of EGFR activation.
Fehrmann
A
A
Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Medizinische Fakultät Carl Gustav Carus, der Technischen Universität, Dresden, Germany.
Dörr
W
W
D000818:Animals; D004307:Dose-Response Relationship, Radiation; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D051379:Mice; D008809:Mice, Inbred C3H; D009061:Mouth Mucosa / Q000528:radiation effects*; D011836:Radiation Tolerance; D014059:Tongue / Q000528:radiation effects*
D066246:ErbB Receptors